{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T19:21:16Z","timestamp":1744572076292},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10147-008-0869-9","type":"journal-article","created":{"date-parts":[[2009,10,24]],"date-time":"2009-10-24T01:21:24Z","timestamp":1256347284000},"page":"468-472","source":"Crossref","is-referenced-by-count":7,"title":["Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis"],"prefix":"10.1007","volume":"14","author":[{"given":"Tadaaki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koushiro","family":"Ohtsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisatsugu","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,25]]},"reference":[{"key":"869_CR1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1200\/JCO.2007.14.5409","volume":"26","author":"C.J. Anker","year":"2008","unstructured":"Anker CJ, Dechet C, Isaac JC, et al. (2008) Small-cell carcinoma of the prostate. J Clin Oncol 26:1168\u20131171","journal-title":"J Clin Oncol"},{"key":"869_CR2","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2002.12.065","volume":"20","author":"C.N. Papandreou","year":"2002","unstructured":"Papandreou CN, Daliani DD, Thall PF, et al. (2002) Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20:3072\u20133080","journal-title":"J Clin Oncol"},{"key":"869_CR3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-5347(17)37427-X","volume":"147","author":"R.J. Amato","year":"1992","unstructured":"Amato RJ, Logothetis CJ, Hallinan R, et al. (1992) Chemotherapy for small cell carcinoma of prostatic origin. J Urol 147:935\u2013937","journal-title":"J Urol"},{"key":"869_CR4","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/1097-0142(19840615)53:12<2728::AID-CNCR2820531231>3.0.CO;2-X","volume":"53","author":"H.G. Taylor","year":"1984","unstructured":"Taylor HG, Lefkowitz M, Skoog SJ, et al. (1984) Intracranial metastases in prostate cancer. Cancer 53:2728\u20132730","journal-title":"Cancer"},{"key":"869_CR5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","volume":"82","author":"M.J. Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Glantz LK, et al. (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82:733\u2013739","journal-title":"Cancer"},{"key":"869_CR6","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1200\/JCO.2008.16.4533","volume":"26","author":"W.B. Bernstein","year":"2008","unstructured":"Bernstein WB, Kemp JD, Kim GS, et al. (2008) Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer. J Clin Oncol 26:3281\u20133284","journal-title":"J Clin Oncol"},{"key":"869_CR7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10147-007-0702-x","volume":"13","author":"M. Katou","year":"2008","unstructured":"Katou M, Soga N, Onishi T, et al. (2008) Small cell carcinoma of the prostate treated with amrubicin. Int J Clin Oncol 13:169\u2013172","journal-title":"Int J Clin Oncol"},{"key":"869_CR8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.urolonc.2005.08.022","volume":"24","author":"M. Yashi","year":"2006","unstructured":"Yashi M, Terauchi F, Nukui A, et al. (2006) Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review. Urol Oncol 24:313\u2013317","journal-title":"Urol Oncol"},{"key":"869_CR9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1200\/JCO.1986.4.11.1620","volume":"4","author":"A.G. Pedersen","year":"1986","unstructured":"Pedersen AG, Becker KL, Bach F, et al. (1986) Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer. J Clin Oncol 4:1620\u20131627","journal-title":"J Clin Oncol"},{"key":"869_CR10","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/1097-0142(20010601)91:11<2122::AID-CNCR1240>3.0.CO;2-8","volume":"91","author":"M.P. Castro","year":"2001","unstructured":"Castro MP, McDonald TJ, Qualman SJ, et al. (2001) Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma. Cancer 91:2122\u20132126","journal-title":"Cancer"},{"key":"869_CR11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0090-4295(92)90235-O","volume":"39","author":"S.R. Moore","year":"1992","unstructured":"Moore SR, Reinberg Y, Zhang G (1992) Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy. Urology 39:411\u2013416","journal-title":"Urology"},{"key":"869_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-5347(17)37390-1","volume":"147","author":"J.E. Oesterling","year":"1992","unstructured":"Oesterling JE, Hauzeur CG, Farrow GM (1992) Small cell anaplastic carcinoma of the prostate. A clinical, pathological and immunohistological study of 27 patients. J Urol 147:804\u2013807","journal-title":"J Urol"},{"key":"869_CR13","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1158\/0008-5472.CAN-04-2442","volume":"64","author":"R.B. Shah","year":"2004","unstructured":"Shah RB, Mehra R, Chinnaiyan AM, et al. (2004) Androgen-independent prostate cancer is a heterogeneous group of diseases. Lessons from a rapid autopsy program. Cancer Res 64:9209\u20139216","journal-title":"Cancer Res"},{"key":"869_CR14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1442-2042.2006.01514.x","volume":"13","author":"H. Aoki","year":"2006","unstructured":"Aoki H, Ishidoya S, Ito A, et al. (2006) Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate. Int J Urol 13:1254\u20131258","journal-title":"Int J Urol"},{"key":"869_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","volume":"3","author":"W.M. Pardridge","year":"2003","unstructured":"Pardridge WM (2003) Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv 3:90\u2013105","journal-title":"Mol Interv"},{"key":"869_CR16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1248\/bpb.22.428","volume":"22","author":"N. Morikawa","year":"1999","unstructured":"Morikawa N, Mori T, Abe T, et al. (1999) Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy. Biol Pharm Bull 22:428\u2013431","journal-title":"Biol Pharm Bull"},{"key":"869_CR17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1215\/15228517-2008-075","volume":"11","author":"J.J. Vredenburgh","year":"2009","unstructured":"Vredenburgh JJ, Desjardins A, Reardon DA, et al. (2009) Experience with irinotecan for the treatment of malignant glioma. Neuro Oncol 11:80\u201391","journal-title":"Neuro Oncol"},{"key":"869_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3816\/CLC.2008.n.006","volume":"9","author":"G. Chen","year":"2008","unstructured":"Chen G, Huynh M, Chen A, et al. (2008) Chemotherapy for brain metastases in small-cell lung cancer. Clin Lung Cancer 9:35\u201338","journal-title":"Clin Lung Cancer"},{"key":"869_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMoa003034","volume":"346","author":"K. Noda","year":"2002","unstructured":"Noda K, Nishiwaki Y, Kawahara M, et al. (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85\u201391","journal-title":"N Engl J Med"},{"key":"869_CR20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2006.08.014","volume":"54","author":"J.H. Sohn","year":"2006","unstructured":"Sohn JH, Choi HJ, Chang J, et al. (2006) A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer. Lung Cancer 54:365\u2013370","journal-title":"Lung Cancer"},{"key":"869_CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.bjc.6603810","volume":"97","author":"H. Okamoto","year":"2007","unstructured":"Okamoto H, Watanabe K, Kunikane H, et al. (2007) Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 97: 162\u2013169","journal-title":"Br J Cancer"},{"key":"869_CR22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0169-5002(02)00073-9","volume":"37","author":"N. Naka","year":"2002","unstructured":"Naka N, Kawahara M, Okishio K, et al. (2002) Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer. Lung Cancer 37:319\u2013323","journal-title":"Lung Cancer"},{"key":"869_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0169-5002(03)00075-8","volume":"40","author":"T. Hirose","year":"2003","unstructured":"Hirose T, Horichi N, Ohmori T, et al. (2003) Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer. Lung Cancer 40:333\u2013338","journal-title":"Lung Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-008-0869-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0869-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:24:50Z","timestamp":1559161490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-008-0869-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1007\/s10147-008-0869-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}